Dr. Leandro Lencina, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $451.82 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exact Sciences Corporation | $149.24 | 7 | $0 (2023) |
| Genentech USA, Inc. | $65.87 | 5 | $0 (2021) |
| Axsome Therapeutics, Inc. | $64.84 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $55.16 | 4 | $0 (2023) |
| Novo Nordisk Inc | $53.64 | 4 | $0 (2023) |
| Daiichi Sankyo Inc. | $31.73 | 2 | $0 (2023) |
| Boston Scientific Corporation | $17.52 | 1 | $0 (2023) |
| PFIZER INC. | $13.82 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $304.10 | 17 | Exact Sciences Corporation ($149.24) |
| 2022 | $81.85 | 6 | AstraZeneca Pharmaceuticals LP ($40.21) |
| 2021 | $50.95 | 4 | Genentech USA, Inc. ($50.95) |
| 2020 | $14.92 | 1 | Genentech USA, Inc. ($14.92) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/07/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Oncology | ||||||
| 08/29/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Neurology | ||||||
| 08/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Oncology | ||||||
| 08/10/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Neurology | ||||||
| 07/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 07/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Oncology | ||||||
| 07/20/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Neurology | ||||||
| 07/11/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Diabetes | ||||||
| 07/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Oncology | ||||||
| 06/09/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/24/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/18/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Neurology | ||||||
| 02/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Oncology | ||||||
| 02/20/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/24/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Oncology | ||||||
| 01/10/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Oncology | ||||||
| 12/05/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/26/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/13/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Diabetes | ||||||
| 08/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
| 11/22/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Virology & Specialty Care | ||||||
| 10/12/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 1,469 | 1,560 | $205,292 | $58,267 |
| 2022 | 27 | 1,001 | 1,040 | $123,744 | $59,461 |
| 2021 | 12 | 1,169 | 1,287 | $307,928 | $114,365 |
| 2020 | 9 | 698 | 728 | $143,983 | $59,304 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 146 | $51,175 | $13,970 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 194 | 203 | $47,215 | $13,344 | 28.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $12,686 | $3,248 | 25.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $4,543 | $3,128 | 68.9% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 26 | 26 | $2,496 | $2,441 | 97.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $8,048 | $2,192 | 27.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 25 | 25 | $6,907 | $2,074 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $5,743 | $1,880 | 32.7% |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | Office | 2023 | 25 | 25 | $2,000 | $1,720 | 86.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 31 | 31 | $3,150 | $1,559 | 49.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 36 | 38 | $2,733 | $1,486 | 54.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 102 | 109 | $4,470 | $1,128 | 25.2% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2023 | 13 | 13 | $1,950 | $955.50 | 49.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 112 | 117 | $5,361 | $890.37 | 16.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 49 | 52 | $5,825 | $855.92 | 14.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 64 | 65 | $5,803 | $852.80 | 14.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 25 | 26 | $5,805 | $741.70 | 12.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 26 | 26 | $2,203 | $731.64 | 33.2% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 102 | 109 | $2,180 | $645.28 | 29.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 26 | 26 | $1,604 | $541.32 | 33.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 24 | 24 | $1,481 | $499.68 | 33.7% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 13 | 13 | $624.00 | $447.07 | 71.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 42 | 42 | $2,706 | $410.96 | 15.2% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2023 | 11 | 11 | $2,777 | $352.97 | 12.7% |
| 84436 | Thyroxine (thyroid chemical), total | Office | 2023 | 47 | 50 | $1,750 | $336.50 | 19.2% |
About Dr. Leandro Lencina, MD
Dr. Leandro Lencina, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bloomfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2010. The National Provider Identifier (NPI) number assigned to this provider is 1285952960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leandro Lencina, MD has received a total of $451.82 in payments from pharmaceutical and medical device companies, with $304.10 received in 2023. These payments were reported across 28 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($451.82).
As a Medicare-enrolled provider, Lencina has provided services to 4,337 Medicare beneficiaries, totaling 4,615 services with total Medicare billing of $291,398. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Bloomfield, NJ
- Active Since 05/05/2010
- Last Updated 09/26/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1285952960
Products in Payments
- Cologuard Collection Kit (Device) $149.24
- Xofluza (Drug) $65.87
- Sunosi (Drug) $64.84
- FARXIGA (Drug) $55.16
- Rybelsus (Drug) $53.64
- INJECTAFER (Drug) $31.73
- WATCHMAN FLX (Device) $17.52
- PAXLOVID (Drug) $13.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Bloomfield
Dr. Marianna Scranton, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $3,810
Dr. Muntasir Khaled, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $3,652
Daniel Mullins, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2,640
Dr. Esira Beaubrun, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,076
Lakshmi Durga Sriramulu, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $634.76
Dr. Silas Shin, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $523.55